These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19815749)

  • 1. Cancer research. Looking for a target on every tumor.
    Kaiser J
    Science; 2009 Oct; 326(5950):218-20. PubMed ID: 19815749
    [No Abstract]   [Full Text] [Related]  

  • 2. An open letter to cancer researchers.
    Elledge SJ; Hannon GJ
    Science; 2005 Oct; 310(5747):439-41. PubMed ID: 16239460
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer research. As questions grow, Duke halts trials, launches investigation.
    Couzin-Frankel J
    Science; 2010 Aug; 329(5992):614-5. PubMed ID: 20688986
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic testing in cancer therapeutics.
    Ezzeldin HH; Diasio RB
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer care expands to include genetic testing.
    Johns Hopkins Med Lett Health After 50; 2009 Jan; 20(11):4-5. PubMed ID: 19408409
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer pharmacogenetics.
    Marsh S
    Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMS and Exelixis target tumor suppression pathways.
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):167. PubMed ID: 12113021
    [No Abstract]   [Full Text] [Related]  

  • 8. Enrichment designs: efficiency in development of cancer treatments.
    Temple RJ
    J Clin Oncol; 2005 Aug; 23(22):4838-9. PubMed ID: 15983397
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer cell line encyclopedia will help researchers match drugs to patients in clinical trials.
    McBride D
    ONS Connect; 2012 Jun; 27(6):21. PubMed ID: 22774345
    [No Abstract]   [Full Text] [Related]  

  • 10. [Individualized anticancer therapies: which regulatory guidelines?].
    Bedairia N; Marty M
    Bull Cancer; 2008 Oct; 95(10):985-8. PubMed ID: 19004730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missing link in genotype-directed cancer therapy.
    Bernards R
    Cell; 2012 Oct; 151(3):465-8. PubMed ID: 23101617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celebrating novel cancer drugs.
    Weiss RA
    Br J Cancer; 2003 Aug; 89(3):425. PubMed ID: 12888806
    [No Abstract]   [Full Text] [Related]  

  • 13. 3rd EORTC-NCI International Meeting on Cancer Molecular Markers: From Discovery to Clinical Practice.
    Taube SE; Gion M; Schilsky RL
    Expert Rev Mol Diagn; 2004 Jul; 4(4):431-3. PubMed ID: 15225090
    [No Abstract]   [Full Text] [Related]  

  • 14. [The experimental chemotherapy of malignant tumors today].
    Syrkin AB; Gerasimova GK; Baryshnikov IuA; Sergeeva NS; Iakubovskaia RI; Bordiushkov IuN
    Vopr Onkol; 1995; 41(2):41-5. PubMed ID: 7483429
    [No Abstract]   [Full Text] [Related]  

  • 15. The cancer gap. No two cancers are alike. But what will it take to give every patient equal care?
    Park A
    Time; 2015 Mar; 185(11):42-7. PubMed ID: 25980069
    [No Abstract]   [Full Text] [Related]  

  • 16. Redefining cancer research.
    Alberts B
    Science; 2009 Sep; 325(5946):1319. PubMed ID: 19745119
    [No Abstract]   [Full Text] [Related]  

  • 17. Facilitating patient-centered cancer research and a new era of drug discovery.
    Niederhuber JE
    Oncologist; 2009 Apr; 14(4):311-2. PubMed ID: 19365096
    [No Abstract]   [Full Text] [Related]  

  • 18. Compilation of 1982 Clinical Trials Summaries published in Cancer Treatment Reports.
    Cancer Treat Rep; 1982 Dec; 66(12):2101-3. PubMed ID: 6754078
    [No Abstract]   [Full Text] [Related]  

  • 19. Aneuploidy and cancer--the vintage wine revisited.
    Bialy H
    Nat Biotechnol; 2001 Jan; 19(1):22-3. PubMed ID: 11135546
    [No Abstract]   [Full Text] [Related]  

  • 20. Progression-free survival remains debatable endpoint in cancer trials.
    Tuma R
    J Natl Cancer Inst; 2009 Nov; 101(21):1439-41. PubMed ID: 19828873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.